Retinoblastoma (Childhood Eye Cancer)

Retinoblastoma (Childhood Eye Cancer), explained simply

Everything a patient or caregiver wants to understand: what retinoblastoma (childhood eye cancer) is, how doctors describe its stage, the standard treatment plan, how radiation works, and the research shaping care today.

On this page

Watch: the CureRays® explainer series

Watch Dr. Hess explain radiation therapyPlain-language videos on how radiation works, what treatment feels like, and what to expect — on the CureRays® YouTube channel.

Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.

What is retinoblastoma (childhood eye cancer)?

Retinoblastoma is a rare cancer that starts in the retina, the light-sensing layer at the back of the eye. It almost always affects young children, usually under age 5, and develops from immature retinal cells that fail to stop growing. The most common first sign is a white glow in the pupil — instead of the normal red-eye seen in flash photos, the pupil may look white or cloudy (called leukocoria); a new eye turn (crossed or wandering eye) is another common sign. Retinoblastoma can affect one eye or both. In many children it is caused by a change in a gene called RB1; when this change is inherited or present in every cell, both eyes are often involved and the child has a higher lifelong risk of other cancers, so genetic counseling is an important part of care. The reassuring news is that, especially when found early, retinoblastoma is one of the most curable childhood cancers — and modern treatment is designed not only to save the child's life but, whenever possible, to save the eye and preserve vision. Care is delivered by a specialized team of children's eye-cancer doctors.

In one line: Retinoblastoma is a rare eye cancer of young children that is highly curable, with modern treatment focused on saving the child's life, the eye, and vision whenever possible.

The main types

Doctors group retinoblastoma (childhood eye cancer) by where it starts and how it behaves:

TypeWhat it means, simply
Unilateral retinoblastomaCancer in one eye only; this is the most common form and is usually not inherited.
Bilateral retinoblastomaCancer in both eyes; this form is almost always caused by an inherited or germline RB1 gene change and needs careful treatment of both eyes.
Heritable (germline) retinoblastomaCases caused by an RB1 change present in every cell of the body; these children need genetic counseling and lifelong monitoring for other cancers.
Trilateral retinoblastomaA rare situation where a related tumor also develops in the brain; it requires intensive treatment and is the reason brain imaging is sometimes done.

Staging, in plain terms

Retinoblastoma uses its own grouping system rather than the TNM system used for adult cancers. For an eye that doctors hope to save, the tumor is sorted into groups A through E based on its size, location within the eye, and whether tumor cells have seeded into the jelly-like center of the eye. Group A means very small tumors with the best chance of saving the eye and vision, while group E means an eye so extensively involved that removal is usually the safest choice. A separate staging system describes whether the cancer has spread beyond the eye. This grouping guides whether the eye can be treated and saved or whether removal is needed, and it helps the team choose among the available eye-saving therapies.

International Classification of Retinoblastoma, groups A–E (not TNM)What it generally means
Group AVery small tumors away from key structures; excellent chance of saving the eye and vision with focused treatments.
Group BLarger tumors still confined to the retina; usually treatable with eye-saving therapy.
Group CTumors with limited seeding of cells into the eye's interior; often still treatable while saving the eye.
Group DTumors with more widespread seeding inside the eye; saving the eye is harder but sometimes possible with intensive therapy.
Group EExtensive disease within the eye; removing the eye is usually the safest way to protect the child's life.
Plain-language takeaway: Staging tells your team how much disease there is and where — but your tumor's biology matters too. Two people described the same way can still have different plans, and that's a good thing.

The standard of care

Retinoblastoma (Childhood Eye Cancer) is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:

Focal eye therapies

Small tumors can be treated directly with laser therapy or freezing (cryotherapy) to destroy the tumor while keeping the eye.

Chemotherapy

Chemotherapy is used to shrink tumors so they can be finished off with focal treatments; it can be given through the bloodstream, injected near the eye, or delivered directly into the eye's artery (intra-arterial chemotherapy).

Plaque brachytherapy (radiation)

A small radioactive disc is stitched onto the outside of the eye over the tumor for a few days, delivering targeted radiation to destroy it while sparing the rest of the body.

External-beam or proton radiation

Focused radiation beams are reserved for tumors that cannot be controlled other ways; proton therapy is favored in children to reduce the risk of later side effects.

Surgery to remove the eye (enucleation)

When an eye is extensively involved and has little chance of useful vision, removing it can be the safest, life-saving choice; a natural-looking artificial eye is fitted afterward.

How radiation treatment works

Radiation uses focused high-energy beams to damage the DNA inside cancer cells so they can no longer grow and divide. Retinoblastoma is sensitive to radiation, which is why radiation can be very effective at saving an eye when other treatments are not enough. Today, doctors most often reach first for focal treatments (laser, freezing) and chemotherapy, and turn to radiation in carefully chosen situations — using plaque brachytherapy, where a small radioactive disc treats the tumor directly, or proton therapy, which concentrates the dose precisely. This careful approach matters especially for children with the inherited form, who carry a higher lifelong risk of developing other cancers; modern radiation is planned to deliver the needed dose to the tumor while sparing the growing face, brain, and healthy eye tissue as much as possible. Treatments are painless, and young children may receive gentle sedation to help them stay still. The goal is always to cure the cancer first, and then to preserve the eye and vision wherever it is safe to do so. Your child's specialized team will explain whether radiation is the best choice in your situation.

The main ways radiation is delivered for retinoblastoma (childhood eye cancer):

Plaque brachytherapy

A tiny radioactive plaque is placed against the eye wall directly over the tumor, delivering a concentrated dose to the tumor over a few days while protecting nearby healthy tissue and the rest of the body.

Proton therapy

Proton beams stop precisely at the tumor, sparing surrounding tissues and lowering the radiation dose to the developing face and brain — especially important for children with inherited disease who face a higher risk of second cancers.

Stereotactic / highly focused external-beam radiation

When external-beam radiation is needed, modern precisely shaped techniques concentrate the dose on the tumor and limit exposure to healthy structures around the eye.

Latest studies shaping care

Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:

Intra-arterial chemotherapy saves more eyes: Delivering chemotherapy directly into the artery that feeds the eye has allowed many eyes to be saved that would once have been removed, and has reduced the need for external-beam radiation.[1]

International retinoblastoma treatment series

Proton therapy to reduce second cancers: For children who need radiation, especially those with inherited disease, proton therapy lowers the radiation dose to healthy tissue and is being studied to reduce the risk of radiation-related second cancers later in life.[2]

Pediatric proton therapy outcome studies

Genetic testing guides care for the whole family: RB1 gene testing now helps identify children with the inherited form so siblings and future children can be screened early, when tumors are smallest and most curable with eye-saving treatment.[3]

Retinoblastoma genetics and screening guidelines

Common questions

Can retinoblastoma be cured? Yes. When found early, retinoblastoma is one of the most curable childhood cancers, with the large majority of children surviving. The first goal is always to cure the cancer and protect the child's life; saving the eye and vision is the next priority whenever it can be done safely.

Will my child lose the eye? Not always. Many eyes are saved today using laser, freezing, chemotherapy, and targeted radiation such as plaque brachytherapy. An eye is usually removed only when it is extensively involved or has little chance of useful vision, in which case removal can be the safest, life-saving choice — and a natural-looking artificial eye is fitted afterward.

Is retinoblastoma inherited? Sometimes. Many one-eye cases are not inherited, but disease in both eyes is almost always caused by a change in the RB1 gene that can run in families and raises the risk of other cancers later. Your team will offer genetic counseling and testing so the whole family can be cared for appropriately.

References

Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.

  1. International retinoblastoma treatment series (no indexed identifier — see your care team)
  2. Pediatric proton therapy outcome studies (no indexed identifier — see your care team)
  3. Retinoblastoma genetics and screening guidelines (no indexed identifier — see your care team)
Medical disclaimer: This guide is general patient education, not medical advice, and reflects widely accepted standards as of 2026. Your situation is unique — always discuss your diagnosis and options with your own care team. CureRays clinicians are here to help you understand your choices.

Talk to a CureRays radiation oncologist Back to all guides